- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
David J. Farber
Events 18 results
Webinar
February 13, 2025
Impact of the 2024 Election on Pharmaceutical, Biologics and Device Manufacturers
Conference
September 5, 2024
17th Annual King & Spalding Medical Device Summit
Speaking Engagement
March 12, 2024
Jeffrey Shapiro and David Farber to Speak at Fogarty Innovation
Conference
November 7, 2023
Pharmaceutical University 2023
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
August 18, 2022
An Analysis of the Prescription Drug Pricing Provisions of the Inflation Reduction Act of 2022
Conference
June 21, 2018
West Coast Pharmaceutical & Medical Device University
Conference
January 12, 2017
An Introduction to the 21st Century Cures Act
Conference
November 15, 2016
9th Annual King & Spalding Pharmaceutical University
Conference
September 20, 2016
What the 2016 Elections Mean for the Pharmaceutical and Device Industries
Conference
July 20, 2016
The New FDA Approach for Expanded Access to Investigational Drugs
Conference
April 7, 2016
West Coast Pharma & Medical Device University